Page 1 of 11 pages :  1 2 3 >  Last »

1. Advances in LLM: New Agents in Early Clinical Trials for CLL Therapy

H&O July 2010 Volume 8, Issue 7

Richard R. Furman, MD

Download PDF

2. Feature Article: Castleman Disease in the 21st Century: An Update on Diagnosis, Assessment, and Therapy

H&O July 2010 Volume 8, Issue 7

Frits van Rhee, MD, PhD, Katie Stone, BS, Susann Szmania, BS, Bart Barlogie, MD, PhD, and Zeba Singh, MD

Download PDF

3. Advances in LLM: Update on Treatments for Patients With Myelodysplastic Syndrome

H&O June 2010 Volume 8, Issue 6

Guillermo Garcia-Manero, MD

Download PDF

4. Advances in LLM: Frontline Regimens for Multiple Myeloma Patients

H&O May 2010 Volume 8, Issue 5

Sagar Lonial, MD

Download PDF

5. Advances in LLM: The Best Frontline Therapy for CML: Imatinib?

H&O April 2010 Volume 8, Issue 4

Giuseppe Saglio, MD

Download PDF

6. Advances in LLM: Rituximab as Therapy for Acute Lymphoblastic Leukemia

H&O March 2010 Volume 8, Issue 3

Deborah A. Thomas, MD

Download PDF

7. Advances in LLM: Updates on the Treatment of Acute Promyelocytic Leukemia

H&O February 2010 Volume 8, Issue 2

Martin S. Tallman, MD

Download PDF

8. Advances in LLM: Ofatumumab: A New Agent for Chronic Lymphocytic Leukemia

H&O January 2010 Volume 8, Issue 1

Anders Österborg, MD, PhD

Download PDF

9. Advances in LLM: Imatinib: High Dose Versus Standard Dose

H&O December 2009 Volume 7, Issue 12

Elias Jabbour, MD

Download PDF

10. Advances in LLM: Update on Burkitt Lymphoma and Leukemia

H&O November 2009 Volume 7, Issue 11

Dieter Hoelzer, MD, PhD

Download PDF

Page 1 of 11 pages :  1 2 3 >  Last »